🔥🐔 BizChicken 🐔🔥
Learn About the Corporations Around You
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Ocular Therapeutix, Inc.
Market Cap: High
Employees: Low
Re Sure Sealant; DEXTENZA; OTX-TKI; OTX-TIC; OTX-CSI
Ocular Therapeutix is a biopharmaceutical company that develops and commercializes therapies for eye diseases using bioresorbable hydrogel-based technology, offering products like Re Sure Sealant and DEXTENZA.
Website
About | About | Leadership | Directors | Contact | Careers | Benefits | Vision/Values | DEI | Careers | About | About | About | About | About | About | About | About | About | About
Symbol: OCUL
Recent Price: $8.35
Industry: Biotechnology
CEO: Dr. Pravin U. Dugel M.D.
Sector: Healthcare
Employees: 267
Address: 24 Crosby Drive, Bedford, MA 01730
Phone: 781 357 4000
Leadership
- Pravin U. Dugel, MD, Executive Chairman, President and CEO
- Karen-Leigh Edwards, PhD, MBA, Chief Operations Officer
- Peter Jarrett, PhD, Chief Technical Officer
- Donald Notman, Chief Financial Officer and Chief Operating Officer
- Nadia K. Waheed, MD, MPH, Chief Medical Officer
- Jeffrey S. Heier, MD, Chief Scientific Officer
- Steve Meyers, Chief Commercial Officer
- Tracy Smith, Vice President, Human Resources
- Sanjay Nayak, MBBS, PhD, Chief Strategy Officer
- Peter K. Kaiser, MD, Chief Development Officer
- Todd Anderman, JD, Chief Legal Officer and Corporate Secretary
- Charles Warden, Lead Independent Director
- Adrienne Graves, PhD, Director
- Leslie Williams, Director
- Richard Lindstrom, MD, Director
- Seung Suh Hong, PhD, Director
- Merilee Raines, Director
Last updated: 2024-12-31